Back to search

Article

A phase 2 trial of peri-operative avelumab and chemotherapy for locally advanced gastro-esophageal adenocarcinoma: Association of AGR2/AP-1 complex CD8 T-cells and M2-Tumour Associated Macrophages with treatment response

2023-12-15

Abstract excerpt

<title>Abstract</title> <p>Perioperative chemo-immunotherapy represents a promising treatment modality for locally advanced gastroesophageal adenocarcinoma (GEA). However, the potential of these novel treatments has yet to be realized and efforts to identify patients who would benefit for targeted therapies have been unsuccessful. Herein we present the clinical results of a phase 2 trial combining neoadjuvant doc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f768e5d8-12c5-58e6-8e9c-e0971101d460
DOI
10.21203/rs.3.rs-3701293/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A phase 2 trial of peri-operative avelumab and chemotherapy for locally advanced gastro-esophageal adenocarcinoma: Association of AGR2/AP-1 complex CD8 T-cells and M2-Tumour Associated Macrophages with treatment responseDOI 10.21203/rs.3.rs-3701293/v1
Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)Semantic proximity
Sequential pembrolizumab cooperates with platinum/5FU to remodel the tumor immune microenvironment in advanced gastric cancer: A phase II chemoimmunotherapy trialSemantic proximity
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapySemantic proximity
Sequential pembrolizumab cooperates with platinum/5FU to remodel the tumor microenvironment in advanced gastric cancer: a phase II chemoimmunotherapy trialSemantic proximity
New directions in perioperative management of locally advanced esophagogastric cancer.Semantic proximity
Targeted Therapies in Neoadjuvant Treatment for Gastroesophageal CancerSemantic proximity
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of responseSemantic proximity
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael adenocarcinomaSemantic proximity
A randomized, open, multicenter Phase II study to explore the sequential use of chemotherapy and immunotherapy in postoperative adjuvant therapy for gastric or esophagogastric junction adenocarcinoma or colorectal adenocarcinoma with radical resection of POLE/POLD1 gene mutation or dMMR/MSI-HSemantic proximity
PD-1 immune checkpoint blockade enhances FLOT chemotherapy toxicity in oesophageal adenocarcinoma cells via immune-independent mechanismsSemantic proximity
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapySemantic proximity
Tumour-Associated Macrophage Polarisation Promotes Progression of Esophageal CarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.